Long non-coding RNA and circular RNA: new perspectives for molecular pathophysiology of atrial fibrillation
- 4 January 2023
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (3) , 2835-2845
Abstract
Many studies have demonstrated the association of atrial fibrillation (AF) with endogenous genetic regulatory mechanisms. These interactions could advance the understanding of the AF pathophysiological process, supporting the search for early biomarkers to improve diagnosis and disease monitoring. Among the endogenous genetic regulatory mechanisms, long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) have gained special attention, and studies have demonstrated their involvement in AF development and other AF-related diseases such as coronary artery disease and cardiomyopathy. This review describes the main experimental results reported by studies that analyzed the expression of lncRNAs and circRNAs in AF associated with miRNA or mRNA. The search was conducted in PubMed public database using the terms “lncRNA and atrial fibrillation” or “long ncRNA and atrial fibrillation” or “long non-coding RNA and atrial fibrillation” or “circular RNA and atrial fibrillation” or “circRNA and atrial fibrillation”. There was no overlapping of lncRNA or circRNA among the studies, attributed to the different sample types, methods, species, and patient classification evaluated in these studies. Although the regulatory mechanisms in which these molecules are involved are not yet well understood, the studies analyzed show their importance in the pathophysiological process of AF, supporting the idea that lncRNAs and circRNAs are involved in miRNA or mRNA regulation in the molecular mechanism of this disease.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (305899/2020-1)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
This publication has 60 references indexed in Scilit:
- Identification of long non-coding RNAs as novel biomarker and potential therapeutic target for atrial fibrillation in old adultsOncotarget, 2016
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive SummaryCirculation, 2014
- Risk Factors and Genetics of Atrial FibrillationCardiology Clinics, 2014
- Role of microRNAs in atrial fibrillation: New insights and perspectivesCellular Signalling, 2013
- The Imprinted H19 LncRNA Antagonizes Let-7 MicroRNAsMolecular Cell, 2013
- Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage CommitmentCell, 2013
- Evolution and Functions of Long Noncoding RNAsCell, 2009
- Energetic metabolism during acute stretch-related atrial fibrillationMolecular and Cellular Biochemistry, 2008
- Atrial Fibrosis: Mechanisms and Clinical Relevance in Atrial FibrillationJACC, 2008
- Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management?Cardiovascular Research, 2002